Back

Prognostic value of reticulocyte production ability in patients with chronic heart failure

2 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Models to predict unfavourable outcomes in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Motoki Nakao

Hokkaido University, Sapporo (Japan)

8 More presentations in this session

Presentation thumbnail
Risk prediction models for incident heart failure: a systematic review and meta-analysis
Mr J. Navarro (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
A flexible, calibrated transformer-based risk model for prediction of clinical outcomes in patients with heart failure; an open cohort study using linked UK EHR
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Explainable machine learning and multi-modal data for predicting readmission in patients with heart failure
Ms R. Chae (US)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis
Doctor V. Anastasiou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge
Professor Y. Zhu (Xiangtan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Models to predict unfavourable outcomes in heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Perennial parameter in intravenous iron therapy for heart failure: reticulocyte crisis
thumbnail
Congress Presentation
Red blood cell distribution width in patients admitted due to acute heart failure with a reduced left ventricular ejection fraction
thumbnail
Congress Presentation
Impact of anemia on clinical profile, treatment patterns and outcomes in heart failure: a retrospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources